[{"from": "human", "value": "What can you tell me about this molecule? [C][C][N][C][C][C][Ring1][=Branch1][C@H1][Branch1][Ring2][C][Ring1][=Branch1][O][C][=Branch1][C][=O][N][C][C][C][=C][C][=C][C][=C][Ring1][=Branch1][C@@H1][Ring1][#Branch2][C][=C][C][=C][C][=C][Ring1][=Branch1]"}, {"from": "gpt", "value": "The molecule is a competitive muscarinic receptor antagonist indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency. It has a long duration of action as it is usually taken once daily.  Solifenacin was granted FDA approval on 19 November 2004."}]